European Union - English - EMA (European Medicines Agency)

pfizer europe ma eeig - pemetrexed ditromethamine - carcinoma, non-small-cell lung; mesothelioma - folic acid analogues, antimetabolites - malignant pleural mesotheliomapemetrexed hospira uk limited in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.non-small cell lung cancerpemetrexed hospira uk limited in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see smpc section 5.1).pemetrexed hospira uk limited is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see smpc section 5.1).pemetrexed hospira uk limited is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see smpc section 5.1).

European Union - English - EMA (European Medicines Agency)

hospira uk limited - docetaxel trihydrate - stomach neoplasms; prostatic neoplasms; breast neoplasms; head and neck neoplasms; carcinoma, non-small-cell lung - antineoplastic agents - breast cancertaxespira in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with:operable node-positive breast cancer;operable node-negative breast cancer.for patients with operable node-negative breast cancer, adjuvant treatment should be restricted to patients eligible to receive chemotherapy according to internationally established criteria for primary therapy of early breast cancer.taxespira in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition.taxespira monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent.taxespira combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours over express her2 and who previously have not received chemotherapy for metastatic disease.taxespira in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracycline.non-small cell lung cancer taxespira indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior chemotherapy.taxespira in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic non-small cell lung cancer, in patients who have not previously received chemotherapy for this condition.prostate cancer taxespira in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone refractory metastatic prostate cancer.gastric adenocarcinoma taxespira in combination with cisplatin and 5-fluorouracil is indicated for the treatment of patients with metastatic gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction, who have not received prior chemotherapy for metastatic disease.head and neck cancer taxespira in combination with cisplatin and 5-fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck.

Singapore - English - HSA (Health Sciences Authority)

kingston medical supplies (private) limited - cardiovascular - suzuken company limited kenz cardico electrocardiograph is intended for the transmission of electrical signals from the patient's heart to the electrocardiograph (ecg)machine. the cable leads are attached to the chest in a given pattern by using electrodes.

Singapore - English - HSA (Health Sciences Authority)

kingston medical supplies (private) limited - cardiovascular - suzuken company limited kenz electrocardiograph is intended for the transmission of electrical signals from the patient's heart to the electrocardiograph (ecg) machine. the cable leads are attached to the chest in a given pattern by using electrodes.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - diltiazem hydrochloride 120.12mg - modified release capsule - 120 mg - active: diltiazem hydrochloride 120.12mg excipient: capsugel light blue turquoise blue 0588 methacrylic acid copolymer methylcellulose microcrystalline cellulose polysorbate 80 purified talc tributyl citrate - diltiazem cd is indicated for the treatment of hypertension either alone or in combination with other antihypertensive medications such as diuretics.

United States - English - NLM (National Library of Medicine)

starcap medical private limited - isopropyl alcohol 70% v/v - antiseptic for preparation of the skin prior to injection; to decrease germs in minor cuts and scrapes.

United States - English - NLM (National Library of Medicine)

zydus lifesciences limited - colchiceine (unii: hj30158l57) (colchiceine - unii:hj30158l57) - colchicine tablets are indicated for prophylaxis and the treatment of acute gout flares. - prophylaxis of gout flares: colchicine tablets are indicated for prophylaxis of gout flares. -   treatment of gout flares: colchicine tablets are indicated for treatment of acute gout flares when taken at the first sign of a flare. colchicine tablets are indicated in adults and children 4 years or older for treatment of familial mediterranean fever (fmf). patients with renal or hepatic impairment should not be given colchicine in conjunction with p-gp or strong cyp3a4 inhibitors (this includes all protease inhibitors except fosamprenavir). in these patients, life-threatening and fatal colchicine toxicity has been reported with colchicine taken in therapeutic doses. pregnancy category c there are no adequate and well-controlled studies with colchicine in pregnant women. colchicine crosses the human placenta. while not studied in the treatment of gout flares, data from a limited number of published studies found no evide

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - pentoxifylline 400mg;  ;   - modified release tablet - 400 mg - active: pentoxifylline 400mg     excipient: erythrosine hyetellose hypromellose macrogol 8000 magnesium stearate povidone purified talc   purified water   titanium dioxide - the treatment of peripheral occlusive vascular disease and circulatory disorders of arteriosclerotic, diabetic, inflammatory or function origin; trophic disorders (e.g., leg ulcers and gangrene).

New Zealand - English - Ministry for Primary Industries

bayer new zealand limited - pyroxasulfone - pyroxasulfone 850 g/kg - herbicide

Philippines - English - FDA (Food And Drug Administration)

agio pharamceuticals limited - drug - silver sulfadiazine - topisulfa